Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Idrugs : the Investigational Drugs Journal|August 31, 2004
Prodrugs: effective solutions for solubility, permeability and targeting challengesLongqin HuMedicinal Research Reviews|December 23, 2014
Targeted prodrug approaches for hormone refractory prostate cancerHerve Aloysius, Longqin HuBioorganic & Medicinal Chemistry|May 9, 2016
Design and synthesis of peptide conjugates of phosphoramide mustard as prodrugs activated by prostate-specific antigenXinghua Wu, Longqin HuBioorganic & Medicinal Chemistry Letters|June 17, 2008
N-(2,2-Dimethyl-2-(2-nitrophenyl)acetyl)-4-aminocyclophosphamide as a potential bioreductively activated prodrug of phosphoramide mustardYongying Jiang, Longqin HuMedicinal Research Reviews|September 15, 2018
Immunomodulators targeting the PD-1/PD-L1 protein-protein interaction: From antibodies to small moleculesJeffrey Yang, Longqin HuBioorganic & Medicinal Chemistry|August 21, 2003
5'-(2-Nitrophenylalkanoyl)-2'-deoxy-5-fluorouridines as potential prodrugs of FUDR for reductive activationBin Liu, Longqin HuActa Pharmaceutica Sinica. B|July 29, 2017
Insects: an underrepresented resource for the discovery of biologically active natural productsLauren Seabrooks, Longqin HuThe Journal of Organic Chemistry|January 5, 2002
Successful Baylis-Hillman reaction of acrylamide with aromatic aldehydesChengzhi Yu, Longqin HuMedicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|May 12, 2020
Nrf2 activation through the inhibition of Keap1-Nrf2 protein-protein interactionSumi Lee, Longqin HuBioorganic & Medicinal Chemistry Letters|October 27, 2006
Phenylalanyl-aminocyclophosphamides as model prodrugs for proteolytic activation: synthesis, stability, and stereochemical requirements for enzymatic cleavageYongying Jiang, Longqin HuPageof 7